You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
葫蘆娃(605199.SH):子公司獲得藥品GMP符合性檢查結果
格隆匯 08-06 16:43

格隆匯8月6日丨葫蘆娃(605199.SH)公佈,全資子公司廣西維威製藥有限公司近日收到廣西壯族自治區藥品監督管理局下發的《藥品GMP符合性檢查結果通知單》。

本次通過GMP符合性檢查為廣西維威在“南寧市防城港路10號”地址核增的液體智能製造中心(口服液體制劑生產線)及2#常温倉庫。在廣西來賓市福興路8號(中藥前處理和提取車間)以及南寧市防城港路10號的液體智能製造中心(口服液體制劑生產線)生產強力枇杷露(國藥準字Z45021573)、蛇膽川貝液(國藥準字Z45021023)、養陰清肺膏(國藥準字Z45021888)。在南寧市防城港路10號的液體智能製造中心(口服液體制劑生產線)生產布洛芬混懸液(國藥準字H20243047)、地氯雷他定口服溶液(國藥準字H20233983)。本次GMP檢查中,液體智能製造中心(口服液體制劑生產線)及2#常温倉庫為廣西維威募投項目“南寧生產基地二期項目”中的一部分。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account